Paneth-like cells produced from OLFM4 + stem cells support OLFM4 + stem cell growth in advanced colorectal cancer.
Mizuho SakaharaTakuya OkamotoUpasna SrivastavaYasuko NatsumeHitomi YamanakaYutaka SuzukiKazutaka ObamaSatoshi NagayamaRyoji YaoPublished in: Communications biology (2024)
Tumor tissues consist of heterogeneous cells that originate from stem cells; however, their cell fate determination program remains incompletely understood. Using patient-derived organoids established from patients with advanced colorectal cancer (CRC), we evaluated the potential of olfactomedin 4 (OLFM4) + stem cells to produce a bifurcated lineage of progenies with absorptive and secretory properties. In the early phases of organoid reconstruction, OLFM4 + cells preferentially gave rise to secretory cells. Additionally, we found that Paneth-like cells, which do not exist in the normal colon, were induced in response to Notch signaling inhibition. Video recordings of single OLFM4 + cells revealed that organoids containing Paneth-like cells were effectively propagated and that their selective ablation led to organoid collapse. In tumor tissues, Paneth-like cells were identified only in the region where tumor cells lost cell adhesion. These findings indicate that Paneth-like cells are directly produced by OLFM4 + stem cells and that their interaction contributes to tumor formation by providing niche factors. This study reveals the importance of the cell fate specification program for building a complete tumor cellular ecosystem, which might be targeted with novel therapeutics.
Keyphrases
- stem cells
- induced apoptosis
- cell fate
- cell cycle arrest
- gene expression
- cell death
- signaling pathway
- cell therapy
- quality improvement
- cancer therapy
- mass spectrometry
- bone marrow
- risk assessment
- high resolution
- drug delivery
- climate change
- drug induced
- pi k akt
- endothelial cells
- high glucose
- simultaneous determination